Related Experiment Video
Updated: Feb 16, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Adhesion molecule with Ig-like domain 1 regulates stability of carotid plaque via TGFβ/Smad signaling pathway by
Xintao Hu1, Xiaoqing Li1, Jichong Chen1
1Department of Vascular Surgery, The Fifth Affiliated Hospital of Zhengzhou University, No. 3 Kangfuqian Street, Erqi District, Zhengzhou 450052, Henan, China.
Insights
AMIGO1 protein stabilizes carotid atherosclerosis plaques by enhancing endothelial cell adhesion and reducing inflammation. It interacts with TGFRII, activating the TGFβ pathway to protect against stroke and related events.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Atherosclerosis Research
Background:
- Carotid atherosclerosis is a major risk factor for cardiovascular and cerebrovascular diseases.
- Maintaining plaque stability is crucial for preventing stroke and transient ischemic attack (TIA).
- Mechanisms governing carotid plaque stability remain incompletely understood.
Purpose of the Study:
- To investigate the molecular mechanisms underlying carotid plaque stability.
- To identify novel therapeutic targets for carotid atherosclerosis (CAS).
Main Methods:
- RNA-sequencing of stable and unstable carotid plaques.
- Functional assays (cell adhesion, cytokine detection).
- Co-immunoprecipitation (Co-IP) and in vivo mouse models (ApoE-/-).
Main Results:
- 594 differentially expressed genes identified; AMIGO1 significantly upregulated in stable plaques.
- AMIGO1 promotes endothelial cell adhesion and downregulates inflammatory cytokines (IL-6, IL-1β, TNF-α).
- AMIGO1 interacts with TGFRII, stabilizing it and activating the TGFβ/SMAD pathway, thereby stabilizing carotid plaques in vivo.
Conclusions:
- AMIGO1 is a key regulator of carotid plaque stability.
- AMIGO1 exerts protective effects by enhancing endothelial function and reducing inflammation via the TGFβ/SMAD pathway.
- AMIGO1 represents a potential therapeutic target for carotid atherosclerosis.
Abstract:
Carotid atherosclerosis is a significant risk factor for cardiovascular and cerebrovascular diseases. Maintaining plaque stability can prevent plaque rupture and thrombus formation, slow disease progression, and is critically important for preventing cerebrovascular events (such as stroke, transient ischemic attack (TIA), and similar events). Mechanisms influencing plaque stability are still unclear. In this study, stable plaques (n = 5) and unstable plaques (n = 5) were collected from patients and analyzed using RNA-sequencing. 594 differently expressed genes were found by RNA-seq. Pathways enriched by KEGG analysis of differentially expressed genes included inflammation related pathway, cell adhesion related pathway and TGFβ signaling pathway. Especially, we found AMIGO1 was significantly upregulated in stable plaques. Functional assays including cell adhesion, and inflammation-related factor detection revealed that AMIGO1 significantly promotes endothelial cell adhesion while downregulating inflammatory cytokines (e.g., IL-6, IL-1β, TNF-α) production, thereby mitigating inflammatory responses. Co-immunoprecipitation (Co-IP) experiments further found that AMIGO1 interacts with transforming growth factor beta receptor II (TGFRII), stabilizing TGFRII protein levels and subsequently activating the TGFβ signaling pathway. AMIGO1 overexpression with AAV9 virus tail vein injection markedly stabilized plaques in ApoE-/- mouse model of carotid atherosclerosis via high-fat diet feeding combined with surgical intervention, with thickened fibrous caps, reduced lipid deposition and decreased immune cell infiltration. These protective effects were abolished upon co-administration of SB431542. Immunofluorescence and western blot analyses of clinical samples corroborated that AMIGO1 enhances carotid plaque stability by upregulating TGFRII level. Our collective data indicated that AMIGO1 regulated stability of plaque by promoting endothelial cell adhesion and downregulating inflammatory cytokines production through activating TGFβ/SMAD pathway via interacting with TGFRII. This study provides a critical theoretical foundation for developing clinical therapies and novel targets for CAS.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Positive Regulator Molecules
Positive Regulator Molecules
Negative Regulator Molecules
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

